Search Page

1

Cite

Share

Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study.

Dröge LA, Perschel FH, Stütz N, Gafron A, Frank L, Busjahn A, Henrich W, Verlohren S. Dröge LA, et al. Hypertension. 2021 Feb;77(2):461-471. doi: 10.1161/HYPERTENSIONAHA.120.15146. Epub 2020 Dec 7. Hypertension. 2021. PMID: 33280406

Cite

Share

2

Cite

Share

A machine-learning-based algorithm improves prediction of preeclampsia-associated adverse outcomes.

Schmidt LJ, Rieger O, Neznansky M, Hackelöer M, Dröge LA, Henrich W, Higgins D, Verlohren S. Schmidt LJ, et al. Among authors: droge la. Am J Obstet Gynecol. 2022 Jul;227(1):77.e1-77.e30. doi: 10.1016/j.ajog.2022.01.026. Epub 2022 Feb 1. Am J Obstet Gynecol. 2022. PMID: 35114187

Cite

Share

3

Cite

Share

Angiosarcomas of Primary Gynecologic Origin - A Case Series and Review of the Literature.

Chinczewski L, Taube ET, Feldhaus FW, DrÖge LA, Chekerov R, Muallem MZ, Pietzner K, Sehouli J, Alavi S. Chinczewski L, et al. Among authors: droge la. Anticancer Res. 2020 Oct;40(10):5743-5750. doi: 10.21873/anticanres.14590. Anticancer Res. 2020. PMID: 32988901

Cite

Share

4

Cite

Share

The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia.

Verlohren S, Dröge LA. Verlohren S, et al. Among authors: droge la. Am J Obstet Gynecol. 2022 Feb;226(2S):S1048-S1058. doi: 10.1016/j.ajog.2020.09.046. Epub 2020 Sep 28. Am J Obstet Gynecol. 2022. PMID: 33002498 Review.

Cite

Share

5

Cite

Share

Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.

Verlohren S, Perschel FH, Thilaganathan B, Dröge LA, Henrich W, Busjahn A, Khalil A. Verlohren S, et al. Among authors: droge la. Hypertension. 2017 Jun;69(6):1192-1197. doi: 10.1161/HYPERTENSIONAHA.117.09256. Epub 2017 May 1. Hypertension. 2017. PMID: 28461601

Cite

Share

6

Cite

Share

Pregnancies in Women Aged 45 Years and Older - a 10-Year Retrospective Analysis in Berlin.

Rendtorff R, Hinkson L, Kiver V, Dröge LA, Henrich W. Rendtorff R, et al. Among authors: droge la. Geburtshilfe Frauenheilkd. 2017 Mar;77(3):268-275. doi: 10.1055/s-0043-100105. Geburtshilfe Frauenheilkd. 2017. PMID: 28392580 Free PMC article.

Cite

Share

7

Cite

Share

The growing body of evidence for the implementation of the soluble fms-like tyrosine kinase 1/placental growth factor ratio into clinical routine.

Verlohren S, Dröge LA. Verlohren S, et al. Among authors: droge la. Am J Obstet Gynecol. 2022 Jan;226(1):157. doi: 10.1016/j.ajog.2021.08.049. Epub 2021 Sep 4. Am J Obstet Gynecol. 2022. PMID: 34487700 No abstract available.

Cite

Share

8

Cite

Share

Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.

Dröge LA, Höller A, Ehrlich L, Verlohren S, Henrich W, Perschel FH. Dröge LA, et al. Pregnancy Hypertens. 2017 Apr;8:31-36. doi: 10.1016/j.preghy.2017.02.005. Epub 2017 Mar 1. Pregnancy Hypertens. 2017. PMID: 28501276

Cite

Share

9

Cite

Share

A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.

Stepan H, Hund M, Gencay M, Denk B, Dinkel C, Kaminski WE, Wieloch P, Semus B, Meloth T, Dröge LA, Verlohren S. Stepan H, et al. Among authors: droge la. Hypertens Pregnancy. 2016 Aug;35(3):295-305. doi: 10.3109/10641955.2016.1141214. Epub 2016 Mar 30. Hypertens Pregnancy. 2016. PMID: 27028698 Free PMC article.

Cite

Share

10

Cite

Share

Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction.

Herraiz I, Dröge LA, Gómez-Montes E, Henrich W, Galindo A, Verlohren S. Herraiz I, et al. Among authors: droge la. Obstet Gynecol. 2014 Aug;124(2 Pt 1):265-273. doi: 10.1097/AOG.0000000000000367. Obstet Gynecol. 2014. PMID: 25004342

Cite

Share